Standout Papers

von Hippel-Lindau disease 2003 2026 2010 2018 1.1k
  1. von Hippel-Lindau disease (2003)
    Russell R. Lonser, G.M. Glenn et al. The Lancet
  2. Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine (2010)
    Steven K. Libutti, Giulio F. Paciotti et al. Clinical Cancer Research

Immediate Impact

12 by Nobel laureates 9 from Science/Nature 79 standout
Sub-graph 1 of 20

Citing Papers

Engineered cellular immunotherapies in cancer and beyond
2022 Standout
Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
2021 Standout

Works of Steven K. Libutti being referenced

Biomanufacturing for clinically advanced cell therapies
2018
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
2010 Standout

Author Peers

Author Last Decade Papers Cites
Steven K. Libutti 4866 4605 3126 326 14.8k
H. Richard Alexander 3475 4815 3754 226 13.5k
Manish K. Aghi 3455 2254 3139 313 11.7k
Alfred K. Lam 5979 4943 1846 542 18.1k
Anthony D. Ho 9465 7396 1602 684 26.9k
Masashi Fukayama 8328 8197 2269 610 23.5k
Gerhard Ehninger 6007 6426 1729 677 24.5k
Lothar Kanz 5676 6541 2446 573 21.7k
Mark Raffeld 6539 13976 2161 423 26.9k
Jean‐Yves Scoazec 4169 7571 6984 497 18.4k
Fulvio Basolo 5484 5505 1993 384 17.5k

All Works

Loading papers...

Rankless by CCL
2026